{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:11:42Z","timestamp":1781716302772,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acute leukemia is an aggressive hematologic malignancy with limited treatment success owing to drug resistance, severe adverse effects, and high costs. Vitexin, a natural compound, demonstrates promising anticancer properties by modulating multiple pathways and inducing apoptosis, while maintaining favorable toxicity profiles. This study examined the pro-apoptotic effects of vitexin on leukemic cell lines (NB-4 and MOLT-4) and patient-derived bone marrow cells, as well as its combined effect with daunorubicin. Cytotoxicity was evaluated using MTT, apoptosis was assessed via Annexin V\/PI flow cytometry, and molecular mechanisms were elucidated through in silico bioinformatic, RT-qPCR, and Western blot analyses. Vitexin decreased cell viability in a dose- and time-dependent manner (48\u00a0hours of IC\n                    <jats:sub>50<\/jats:sub>\n                    : 901 \u00b5M in NB-4, 929 \u00b5M in MOLT-4), with minimal toxicity in normal PBMCs. Synergistic interaction with daunorubicin was confirmed through the combination index. Vitexin elevated apoptosis up to 42.82% by downregulating HIF-1\u03b1 and upregulating caspase-3 at both transcriptional and translational levels. Patient-derived bone marrow cells, the combination treatment induced the highest apoptosis (22.15% AML, 18.82% ALL). Vitexin induces apoptosis via modulation of HIF-1\u03b1\/Bcl-2\/caspase-3 pathway and potentiates efficacy of daunorubicin, thereby supporting potential as an adjunctive therapeutic in acute leukemia. Further in vivo studies are necessary to elucidate pharmacokinetics and clinical applicability.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-32789-y","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T13:13:36Z","timestamp":1765718016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vitexin induces apoptosis and enhances daunorubicin efficacy in acute leukemia via modulation of the HIF-1\u03b1\/Bcl-2\/caspase-3 pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Chutiphong","family":"Jirawatpraphakorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalina","family":"Tanyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attasak","family":"Jaree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerapat","family":"Owattanapanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"issue":"11","key":"32789_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber, D. A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic clinical and genomic data. Blood 140(11), 1200\u20131228 (2022).","journal-title":"Blood"},{"key":"32789_CR2","unstructured":"Chennamadhavuni, A., Iyengar, V., Mukkamalla, S. K. R. & Shimanovsky, A. Leukemia. StatPearls. Treasure Island (FL): StatPearls Publishing, Copyright \u00a9 2024 (StatPearls Publishing LLC, 2025)."},{"issue":"4","key":"32789_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.beha.2017.10.002","volume":"30","author":"JE Churpek","year":"2017","unstructured":"Churpek, J. E. Familial myelodysplastic syndrome\/acute myeloid leukemia. Best Pract. Res. Clin. Haematol. 30(4), 287\u2013289 (2017).","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"3","key":"32789_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.7748\/ns.2023.e11963","volume":"38","author":"C Arbuckle","year":"2023","unstructured":"Arbuckle, C. Exploring the use of alternative diets in people living with cancer. Nurs. Stand. 38(3), 63\u201368 (2023).","journal-title":"Nurs. Stand."},{"issue":"10","key":"32789_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1742-1241.2012.02945.x","volume":"66","author":"PE Harris","year":"2012","unstructured":"Harris, P. E., Cooper, K. L., Relton, C. & Thomas, K. J. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int. J. Clin. Pract. 66(10), 924\u2013939 (2012).","journal-title":"Int. J. Clin. Pract."},{"issue":"16_suppl","key":"32789_CR6","doi-asserted-by":"publisher","first-page":"e24070","DOI":"10.1200\/JCO.2024.42.16_suppl.e24070","volume":"42","author":"J Matriz","year":"2024","unstructured":"Matriz, J., Hamachi, A. & Fukui, J. A. The use of complementary and alternative medicine (CAM) among patients with cancer in Hawaii. J. Clin. Oncol. 42(16_suppl), e24070\u2013e (2024).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"32789_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7861\/clinmedicine.13-2-126","volume":"13","author":"P Posadzki","year":"2013","unstructured":"Posadzki, P., Watson, L. K., Alotaibi, A. & Ernst, E. Prevalence of use of complementary and alternative medicine (CAM) by patients\/consumers in the UK: systematic review of surveys. Clin. Med. (Lond). 13(2), 126\u2013131 (2013).","journal-title":"Clin. Med. (Lond)"},{"key":"32789_CR8","doi-asserted-by":"publisher","first-page":"102644","DOI":"10.1016\/j.pmedr.2024.102644","volume":"39","author":"M Yousefi","year":"2024","unstructured":"Yousefi, M., Reihani, H., Heydari, M., Nasimi Doost Azgomi, R. & Hashempur, M. H. Complementary and alternative medicine use among cancer patients in Iran: A systematic review. Prev. Med. Rep. 39, 102644 (2024).","journal-title":"Prev. Med. Rep."},{"issue":"4","key":"32789_CR9","doi-asserted-by":"publisher","first-page":"167378","DOI":"10.1016\/j.jmb.2021.167378","volume":"434","author":"N Ketelut-Carneiro","year":"2022","unstructured":"Ketelut-Carneiro, N. & Fitzgerald, K. A. Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die. J. Mol. Biol. 434(4), 167378 (2022).","journal-title":"J. Mol. Biol."},{"issue":"4","key":"32789_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35(4), 495\u2013516 (2007).","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"32789_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41420-023-01581-0","volume":"9","author":"S Shen","year":"2023","unstructured":"Shen, S., Shao, Y. & Li, C. Different types of cell death and their shift in shaping disease. Cell. Death Discov. 9(1), 284 (2023).","journal-title":"Cell. Death Discov"},{"key":"32789_CR12","unstructured":"Alberts, B. J. A. et al. Programmed Cell Death (Apoptosis). 4th edition ed: Molecular Biology of the Cell. (2002)."},{"issue":"3","key":"32789_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","volume":"26","author":"LA Booth","year":"2014","unstructured":"Booth, L. A., Tavallai, S., Hamed, H. A., Cruickshanks, N. & Dent, P. The role of cell signalling in the crosstalk between autophagy and apoptosis. Cell. Signal. 26(3), 549\u2013555 (2014).","journal-title":"Cell. Signal."},{"issue":"4","key":"32789_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41419-021-03528-8","volume":"12","author":"U Karmakar","year":"2021","unstructured":"Karmakar, U. et al. Immune complex-induced apoptosis and concurrent immune complex clearance are anti-inflammatory neutrophil functions. Cell. Death Dis. 12(4), 296 (2021).","journal-title":"Cell. Death Dis."},{"issue":"9","key":"32789_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait, S. W. & Green, D. R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell. Biol. 11(9), 621\u2013632 (2010).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"32789_CR16","doi-asserted-by":"crossref","unstructured":"Yutharaksanukul, P. et al. Effects of purified vitexin and iso-vitexin from mung bean seed coat on antihyperglycemic activity and gut microbiota in overweight individuals\u2019 modulation. Nutrients. 16(17) (2024).","DOI":"10.3390\/nu16173017"},{"issue":"12","key":"32789_CR17","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1007\/s12649-021-01493-z","volume":"12","author":"S Maneewan","year":"2021","unstructured":"Maneewan, S., Tangpromphan, P. & Jaree, A. Separation of vitexin and Iso-vitexin from mung bean seed coats using a three-zone simulated moving bed (SMB). Waste Biomass Valoriz. 12(12), 6601\u20136618 (2021).","journal-title":"Waste Biomass Valoriz."},{"issue":"1","key":"32789_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40659-019-0214-y","volume":"52","author":"X Liu","year":"2019","unstructured":"Liu, X., Jiang, Q., Liu, H. & Luo, S. Vitexin induces apoptosis through mitochondrial pathway and PI3K\/Akt\/mTOR signaling in human non-small cell lung cancer A549 cells. Biol. Res. 52(1), 7 (2019).","journal-title":"Biol. Res."},{"issue":"3","key":"32789_CR19","first-page":"197","volume":"11","author":"R Najafipour","year":"2022","unstructured":"Najafipour, R., Momeni, A. M., Mirmazloomi, Y. & Moghbelinejad, S. Vitexin induces apoptosis in MCF-7 breast cancer cells through the regulation of specific MiRNAs expression. Int. J. Mol. Cell. Med. 11(3), 197\u2013206 (2022).","journal-title":"Int. J. Mol. Cell. Med."},{"issue":"3","key":"32789_CR20","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.18632\/oncotarget.22890","volume":"9","author":"M Bhardwaj","year":"2018","unstructured":"Bhardwaj, M. et al. Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget 9(3), 3278\u20133291 (2018).","journal-title":"Oncotarget"},{"issue":"4","key":"32789_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5230\/jgc.2021.21.e40","volume":"21","author":"P Zhou","year":"2021","unstructured":"Zhou, P. et al. Vitexin inhibits gastric cancer growth and metastasis through HMGB1-mediated inactivation of the PI3K\/AKT\/mTOR\/HIF-1alpha signaling pathway. J. Gastric Cancer. 21(4), 439\u2013456 (2021).","journal-title":"J. Gastric Cancer"},{"issue":"3","key":"32789_CR22","first-page":"276","volume":"42","author":"M Mubeen","year":"2025","unstructured":"Mubeen, M., Ali, H., Zehra, S. S. & Khan, A. Harnessing the power of vitexin as a vitamin D receptor agonist in colorectal cancer: A new frontier. Balkan Med. J. 42(3), 276\u2013278 (2025).","journal-title":"Balkan Med. J."},{"key":"32789_CR23","doi-asserted-by":"crossref","unstructured":"Khoja, K. K. et al. Cytotoxicity of fenugreek sprout and seed extracts and their bioactive constituents on MCF-7 breast cancer cells. Nutrients. 14(4) (2022).","DOI":"10.3390\/nu14040784"},{"issue":"1","key":"32789_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/nyas.13446","volume":"1401","author":"K Ganesan","year":"2017","unstructured":"Ganesan, K. & Xu, B. Molecular targets of vitexin and isovitexin in cancer therapy: a critical review. Ann. N Y Acad. Sci. 1401(1), 102\u2013113 (2017).","journal-title":"Ann. N Y Acad. Sci."},{"key":"32789_CR25","doi-asserted-by":"publisher","first-page":"112527","DOI":"10.1016\/j.jep.2019.112527","volume":"251","author":"MK Sarkar","year":"2020","unstructured":"Sarkar, M. K., Mahapatra, S. K. & Vadivel, V. Oxidative stress mediated cytotoxicity in leukemia cells induced by active phyto-constituents isolated from traditional herbal drugs of West Bengal. J. Ethnopharmacol. 251, 112527 (2020).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"32789_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/jpp\/rgab085","volume":"74","author":"MK Sarkar","year":"2022","unstructured":"Sarkar, M. K., Kar, A., Jayaraman, A., Kar Mahapatra, S. & Vadivel, V. Vitexin isolated from prosopis cineraria leaves induce apoptosis in K-562 leukemia cells via Inhibition of the BCR-ABL-Ras-Raf pathway. J. Pharm. Pharmacol. 74(1), 103\u2013111 (2022).","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"32789_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/13880209.2023.2190774","volume":"61","author":"C Liang","year":"2023","unstructured":"Liang, C., Jiang, Y. & Sun, L. Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K\/AKT pathway. Pharm. Biol. 61(1), 581\u2013589 (2023).","journal-title":"Pharm. Biol."},{"issue":"16","key":"32789_CR28","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1158\/1078-0432.CCR-09-0661","volume":"15","author":"Y Zhou","year":"2009","unstructured":"Zhou, Y. et al. Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin. Cancer Res. 15(16), 5161\u20135169 (2009).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"32789_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12885-019-5377-y","volume":"19","author":"HM Al-Aamri","year":"2019","unstructured":"Al-Aamri, H. M. et al. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia. BMC Cancer. 19(1), 179 (2019).","journal-title":"BMC Cancer"},{"issue":"8","key":"32789_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/cncr.33477","volume":"127","author":"HM Kantarjian","year":"2021","unstructured":"Kantarjian, H. M., Kadia, T. M., DiNardo, C. D., Welch, M. A. & Ravandi, F. Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach. Cancer 127(8), 1186\u20131207 (2021).","journal-title":"Cancer"},{"issue":"1","key":"32789_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3324\/haematol.2021.280161","volume":"107","author":"JM Rowe","year":"2022","unstructured":"Rowe, J. M. The 7\u2009+\u20093 regimen in acute myeloid leukemia. Haematologica 107(1), 3 (2022).","journal-title":"Haematologica"},{"issue":"23","key":"32789_CR32","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1080\/14786419.2019.1566818","volume":"34","author":"MK Sarkar","year":"2020","unstructured":"Sarkar, M. K., Vadivel, V., Raja, M. R. C. & Kar Mahapatra, S. Investigation of phytochemical constituents of anti-leukemic herbal drugs used by the traditional healers of Purulia, Birbhum and Bankura districts of West Bengal. Nat. Prod. Res. 34(23), 3388\u20133393 (2020).","journal-title":"Nat. Prod. Res."},{"issue":"22","key":"32789_CR33","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.3390\/molecules25225243","volume":"25","author":"A Ullah","year":"2020","unstructured":"Ullah, A. et al. Important flavonoids and their role as a therapeutic agent. Molecules 25(22), 5243 (2020).","journal-title":"Molecules"},{"issue":"2","key":"32789_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70(2), 440\u2013446 (2010).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32789-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:07:37Z","timestamp":1769220457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32789-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32789-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using human acute leukemic bone marrow samples. Ethics approval was obtained from the Siriraj Institutional Review Board SIRB (MU-MOU CoA No. 085\/2025), and written informed consent was obtained from all patients prior to sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"Written informed consent was obtained from all participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2992"}}